People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Pharma, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Xios Therapeutics, Inc. | — | Pharma | Series A | $7.0M | $31.0M | 2015 |
| Enhance Entertainment, LLC | — | Other | Seed | $3.6M | $27.9M | 2012 |
| Tek84 Inc. | — | Other Technology | Seed | $2.8M | $24.2M | 2023 |
Rick Wagner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rick Wagner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JEFF BIRD | 1 | 7 |
| Steven Smith | 1 | 7 |
| Richard Wagner | 1 | 2 |
| Kevin Russeth | 1 | 2 |
| Jonathan Shultz | 1 | 2 |
| Russell Hoffman | 1 | 1 |
| Diala Ezzeddine | 1 | 1 |
| Patrick Byrd | 1 | 1 |
| Warren Muir | 1 | 1 |
| Rich Wagner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.